SCHEMBL6124306

SCHEMBL6124306

CCCCN(C)C1CC(C)(C)NC(C)(C)C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.32
ALDH1A1 P00352 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22597519 0.92 DNM1 (0.40) ALOX15ALDH1A1NPSR1
SCHEMBL10064561 0.88 ALDH1A1 (0.33) ALOX15ALDH1A1NPSR1
SCHEMBL206150 0.84
SCHEMBL17945926 0.84 ALDH1A1 (0.33) ALOX15ALDH1A1NPSR1
SCHEMBL12755553 0.83 DRD2 (0.32)
SCHEMBL11543220 0.82 CHRM2 (0.31) ALOX15ALDH1A1NPSR1
SCHEMBL20018683 0.81 ALOX15 (0.31) ALOX15
SCHEMBL15959821 0.80 ALOX15 (0.31) ALOX15
SCHEMBL17946111 0.79 ALDH1A1 (0.33) ALOX15ALDH1A1NPSR1
SCHEMBL18754417 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230366128-A1 UHMWPE FIBER AVIENT PROTECTIVE MAT B V (NL) 2023-11-16 US disclosed
US-20230366128-A1 UHMWPE FIBER AVIENT PROTECTIVE MAT B V (NL) 2023-11-16 US disclosed
WO-2023109506-A1 POLYMERIC STERICALLY HINDERED AMINE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 天集化工助剂(沧州)有限公司 2023-06-22 WO disclosed
EP-3048097-B2 METHOD FOR PRODUCING AN N-METHYL SUBSTITUTED TRIACETONE AMINE COMPOUND EVONIK OPERATIONS GMBH (DE) 2021-12-01 EP disclosed
EP-3048097-B1 METHOD FOR PRODUCING AN N-METHYL SUBSTITUTED TRIACETONE AMINE COMPOUND EVONIK DEGUSSA GMBH (DE) 2019-04-24 EP disclosed
WO-2019035072-A1 ACRYLIC COMPOSITIONS INCLUDING A HINDERED AMINE LIGHT STABILIZER AND METHODS OF MAKING AND USING THE SAME GLEN RAVEN, INC. (US) 2019-02-21 WO disclosed
US-9617245-B2 Process for preparing an N-methyl-substituted triacetonamine compound EVONIK DEGUSSA GMBH (DE) 2017-04-11 US disclosed
US-9617245-B2 Process for preparing an N-methyl-substituted triacetonamine compound EVONIK DEGUSSA GMBH (DE) 2017-04-11 US disclosed
EP-2271698-B1 CONTINUOUS PROCESS FOR PRODUCING A REACTIVE POLYMER EVONIK DEGUSSA GMBH (DE) 2016-11-23 EP disclosed
US-20160214962-A1 PROCESS FOR PREPARING AN N-METHYL-SUBSTITUTED TRIACETONAMINE COMPOUND EVONIK DEGUSSA GMBH (DE) 2016-07-28 US disclosed
EP-2271709-B1 POLYMER COMPOSITION COMPRISING PHENOLIC RESIN EVONIK DEGUSSA GMBH (DE) 2011-08-03 EP disclosed
US-20110152411-A1 POLYMER COMPOSITION COMPRISING PHENOLIC RESIN EVONIK DEGUSSA GMBH (DE) 2011-06-23 US disclosed
US-20110152411-A1 POLYMER COMPOSITION COMPRISING PHENOLIC RESIN EVONIK DEGUSSA GMBH (DE) 2011-06-23 US disclosed
WO-2009132924-A1 POLYMER COMPOSITION COMPRISING PHENOLIC RESIN EVONIK DEGUSSA GMBH (DE) 2009-11-05 WO disclosed
WO-2009132923-A1 CONTINUOUS PROCESS FOR PRODUCING A REACTIVE POLYMER EVONIK DEGUSSA GMBH (DE) 2009-11-05 WO disclosed
US-20090198039-A1 PROCESS FOR THE PREPARATION OF A POLYMER HAVING IMPROVED DYEABILITY DSM IP ASSETS B.V. (NL) 2009-08-06 US disclosed
US-20090198039-A1 PROCESS FOR THE PREPARATION OF A POLYMER HAVING IMPROVED DYEABILITY DSM IP ASSETS B.V. (NL) 2009-08-06 US disclosed
US-20080153948-A1 Additive functionalized organophilic nano-scaled fillers CAMENZIND HUGO 2008-06-26 US disclosed
WO-2007057265-A2 TRIAZINE COMPOUNDS COMPRISING SUBSTITUENTS CONTAINING AMINO GROUPS AND CARBOXYL GROUPS EVONIK DEGUSSA GMBH (DE) 2007-05-24 WO disclosed
EP-1787989-A1 Triazine derivatives containing amino and carboxylic acic group Degussa GmbH (DE) 2007-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214962-A1 PROCESS FOR PREPARING AN N-METHYL-SUBSTITUTED TRIACETONAMINE COMPOUND HNMT, COMT, PNMT ALOX15 3446/4885ALDH1A1 1129/4885NPSR1 2430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.